Post by
Noteable on Dec 04, 2023 11:14am
ONCY pelareorep as a potential bispecific or ADC payload.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175114/
Comment by
Noteable on Dec 04, 2023 12:05pm
Galon, J. & Bruni, D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat. Rev. Drug Discov. 18, 197–218 (2019).
Comment by
Noteable on Dec 04, 2023 3:25pm
Plenty of opportunities for ONCY.
Comment by
Noteable on Dec 04, 2023 6:40pm
This for those fvery ew who are fixed on stock options.
Comment by
Noteable on Dec 04, 2023 6:40pm
Should read ... those very few ..